why choose us

First received: May 15, 2023

Clinical Trial: A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Study Status: Completed

Recruit Status: RECRUITING

Condition: Subjects With Renal Impairment

Study Type: INTERVENTIONAL


Official Title: A Non-Random, Open-label, Parallel-group Study to Assess the Pharmacokinetics of JT001 in Subjects With Mild and Moderate Renal Impairment Compared to Subjects With Normal Renal Function

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics and safety of a single dose of JT001 in adult subjects with mild and moderate renal impairment compared to healthy mean-matched subjects.The results of this study will guide the clinical recommendation regarding whether or not a dose adjustment may be needed when treating patients with renal impairment.

Read more